COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control

Letter Allergy

Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology

Anurag Bhalla et al.

ALLERGY (2021)

Add to Collection

Letter Allergy

COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey

Andrea Matucci et al.

ALLERGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity

Marco Caminati et al.

Summary: Analysis of medical records of hospitalized COVID-19 asthmatic patients in Italy revealed a low prevalence of asthma, but patients with GINA 4/5 asthma and those not adequately treated may be at higher risk.

RESPIRATORY MEDICINE (2021)

Add to Collection

Editorial Material Immunology

Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?

Marco Caminati et al.

VACCINES (2021)

Add to Collection

Article Rheumatology

EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs

Johannes W. J. Bijlsma

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Editorial Material Immunology

Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines

John M. Kelso

VACCINE (2021)

Add to Collection

Article Immunology

Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system

Emily Jane Woo et al.

Summary: The study reviewed adverse event reports following vaccination with the quadrivalent recombinant influenza vaccine, finding that the majority were non-serious events. In some cases, allergic reactions were reported, including two individuals experiencing positive rechallenge. It is important to consider the potential underlying predisposition in individuals and continue postmarketing safety surveillance.

VACCINE (2021)

Add to Collection

Article Allergy

COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee

Paul J. Turner et al.

Summary: Vaccines against COVID-19 are crucial for controlling the pandemic, with most adverse events being a result of immune response rather than allergic reactions. Although anaphylaxis is rare with vaccines, recent data on reactions to the Pfizer-BioNTech vaccine suggest a closer incidence rate of 1 in 200,000 doses. A global surveillance strategy led by allergists is proposed to gather data and provide evidence-based guidance to public health bodies and the public for reassurance.

WORLD ALLERGY ORGANIZATION JOURNAL (2021)

Add to Collection

Article Immunology

The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland

Piotr Rzymski et al.

Summary: The study demonstrates varying levels of trust in COVID-19 vaccines across producers, with mRNA vaccines being received with high acceptance. It emphasizes the need for effective and continuous science communication when fighting the pandemic.

VACCINES (2021)

Add to Collection

Article Respiratory System

The impact of COVID-19 on patients with asthma

Jose Luis Izquierdo et al.

Summary: The study analyzed clinical data of 71,182 asthma patients and found that those with COVID-19 were older, predominantly female, and had higher prevalence of comorbidities. The use of inhaled corticosteroids and biologics in asthma patients may have a protective effect against severe COVID-19 infection.

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Article Respiratory System

Effect of asthma and asthma medication on the prognosis of patients with COVID-19

Yong Jun Choi et al.

Summary: The study found that asthma patients with COVID-19 had a significantly higher mortality rate than other patients, but asthma was not an independent risk factor for the clinical outcomes of COVID-19. Furthermore, asthma medication use and asthma severity did not affect the clinical outcomes of COVID-19.

EUROPEAN RESPIRATORY JOURNAL (2021)

Add to Collection

Review Allergy